IXP

Investor type

VC

Founded

2023

AUM

$24 M

Location

Hyderabad, Telangana, India

Investment Ticket

$10-50 m

Investment Stage

Pre-seed Seed

Region of investment

Asia
Investor profile last updated: 16 August, 2026

Profile

IXP, an acronym for Innovation Acceleration Platform, acts as a growth engine for Lifesciences startups to seed and scale innovative ideas. The platform is built on the premise that the rate-limiting step for a scientist on an entrepreneurial journey is not funding alone, but also availability of laboratory space, access to networks of seasoned entrepreneurs/partners in the industry and curated services for externalization of R&D. We catalyse scaling of early-stage companies through access to seed-/growth- capital, ready-to-move labs and strong industry connects. The key differentiator for the platform is the well-networked team with diverse expertise at the intersection of private equity and Lifesciences R&D.

Industry

Biotechnology Medical Devices Pharmaceuticals MedTech Life Sciences HealthTech

IXP Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
IXP Lifesciences Catalyst Fund
Venture Capital (VC)
Medical Devices
MedTech
Life Sciences
HealthTech
Pre-seed
Seed
Series A
Asia
$5-10 m
$23 M
February 2025

Contacts

Name
Title
Email
avatar
Bharat Gulechha Associate
Associate
b•••@•••
avatar
Vedika Vaity Analyst
Analyst
v•••@•••
Upgrade to see contacts
avatar
ofY2JOgA85k7dTVm ofY2JOgA85k7dTVm
ofY2JOgA85k7dTVm
avatar
ofY2JOgA85k7dTVm ofY2JOgA85k7dTVm
ofY2JOgA85k7dTVm
avatar
ofY2JOgA85k7dTVm ofY2JOgA85k7dTVm
ofY2JOgA85k7dTVm
Investment-team contacts for IXP — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about IXP

IXP is a venture capital firm. It backs companies at Pre-seed and Seed, writing tickets of $10-50 m.
IXP is located in Hyderabad, Telangana, India.
IXP was founded in 2023.
IXP invests in companies and startups in Biotechnology, Medical Devices, Pharmaceuticals, MedTech, Life Sciences, HealthTech.
IXP invests in companies and startups in Asia.
IXP invests in companies and startups at Pre-seed, Seed.
IXP usually invests $10-50 m on average.
IXP has around $24m assets under management.
IXP last fund was created/launched in 2025-02-11
IXP can be reached through its website ixplifesciences.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for IXP — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query IXP directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.